Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eriksson, T.
Right arrow Articles by Carlsson, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eriksson, T.
Right arrow Articles by Carlsson, A.
NEUROLOGY 1988;38:1245
© 1988 American Academy of Neurology

'On-off' phenomenon in Parkinson's disease

Relationship between dopa and other large neutral amino acids in plasma

Tomas Eriksson, MD, PhD, Ann-Kathrine Granérus, MD, PhD, Anders Linde, OD, PhD and Arvid Carlsson, MD, PhD

Department of Pharmacology, Valla Hospital, University of Linköping, Sweden (Drs. Eriksson and Carlsson)
Laboratory of Oral Biology, University of Göteborg-, Valla Hospital, University of Linköping, Sweden (Dr. Linde)
Department of Geriatrics and Long Term Care Medicine, Valla Hospital, University of Linköping, Sweden (Dr. Granérus).

Administration of a low-protein diet to parkinsonian patients with "on-off" syndromes consistently increased the total daily time of "on" states when compared with a high-protein diet. The clinical effect of the low-protein diet may be due to a marked decrease in the plasma concentration of large neutral amino acids that compete with L-dopa for carrier-mediated transport into the brain.

Address correspondence and reprint requests to Dr. Eriksson, Department of Pharmacology, University of Göteborg, PO Box 33031, S-400 33 Göteborg, Sweden.

Supported by Merck Sharp & Dohme (Sweden) AB, The Swedish Medical Research Council, and the Göteborg Medical Society.

Received September 25, 1985. Accepted for publication in final form December 29, 1987.




This article has been cited by other articles:


Home page
Arch NeurolHome page
P. J. Karstaedt and J. H. Pincus
Protein Redistribution Diet Remains Effective in Patients With Fluctuating Parkinsonism
Arch Neurol, February 1, 1992; 49(2): 149 - 151.
[Abstract] [PDF]


Home page
Arch NeurolHome page
P. J. Karstaedt, J. H. Pincus, and S. S. Coughlin
Standard and Controlled-Release Levodopa/Carbidopa in Patients With Fluctuating Parkinson's Disease on a Protein Redistribution Diet: A Preliminary Report
Arch Neurol, April 1, 1991; 48(4): 402 - 405.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by AAN Enterprises, Inc.